TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biomedola AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,021
|
1,167
|
966 |
| Financial expenses |
65
|
0
|
0 |
| Earnings before taxes |
1,482
|
817
|
743 |
| EBITDA |
492
|
780
|
743 |
| Total assets |
6,181
|
5,045
|
4,516 |
| Current assets |
3,999
|
3,093
|
2,565 |
| Current liabilities |
199
|
209
|
148 |
| Equity capital |
5,670
|
4,521
|
4,068 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
91.7%
|
89.6%
|
90.1% |
| Turnover per employee |
1,021
|
1,167
|
966 |
| Profit as a percentage of turnover |
145.2%
|
70.0%
|
76.9% |
| Return on assets (ROA) |
25.0%
|
16.2%
|
16.5% |
| Current ratio |
2009.5%
|
1479.9%
|
1733.1% |
| Return on equity (ROE) |
26.1%
|
18.1%
|
18.3% |
| Change turnover |
-146
|
201
|
185 |
| Change turnover % |
-13%
|
21%
|
24% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.